Mondaq India: Food, Drugs, Healthcare, Life Sciences
Singh & Associates
The calculation methodology of the fixation of price for drugs is a complicated one and recently we have come across yet another case of using incorrect methodology for price fixation...
S.S. Rana & Co. Advocates
In 2015, India's apex food regulator, theFSSAI, had ordered recall of energy drinks, Tzinga, Cloud 9, Monster Energy from the market declaring ingredients in these energy beverages were not safe.
Nishith Desai Associates
The Central Government has clarified that the institutional collaboration between Bill & Melinda Gates Foundation and National Technical Advisory Group on Immunization is not financially linked.
S.S. Rana & Co. Advocates
The Government of India, under the aegis of Ministry of Health and Family Welfare has notified the Medical Devices Rules, 2017, which is scheduled to come into force on January 1, 2018.
Khaitan & Co
At present, the Drugs and Cosmetics Rules, 1945 (Drugs Rules) regulate 15 categories of medical devices as drugs.
Nishith Desai Associates
United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila's wholly owned subsidiary Zydus Healthcare Limited.
Nishith Desai Associates
The medical device industry is, without a doubt, one of India's sunrise industries as it has consistently outshone many other industries in terms of year on year growth.
ARA LAW
While the economy is witnessing a fast transition from "offline" to "online" markets and there is a sturdy buzz of "demonetization" and "one click" access to everything, . . .
Khaitan & Co
FDCs are combinations of two or more active pharmaceutical ingredients in fixed ratios, given in the form of a single dose.
Kochhar & Co.
Food processing includes all the processes under filtration, manufacturing and preservation techniques undertaken for bringing value addition to the agricultural or horticultural produce.
S.S. Rana & Co. Advocates
CDSCO is the national regulatory authority in India that evaluates safety, efficacy and quality of drugs in the country.
Khaitan & Co
The Hon'ble Supreme Court of India has, in the case of State of Uttar Pradesh v Dr Dinesh Singh Chauhan, struck down the practice of grant of reservation for in-service candidates in post graduate medical degree courses.
Singh & Associates
The regulatory framework relating to clinical trial of drugs is governed under the Drugs and Cosmetics Act, 1940 ("Act") and the Drugs and Cosmetics Rules, 1945.
Singh & Associates
In an information release by Press Information Bureau on 14th May 2016, Ministry of AYUSH Government of India and the World Health organization (WHO) have signed an historic Project Collaboration Agreement (PCA) for cooperation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine.
Nishith Desai Associates
TPG Growth has acquired a significant majority stake in Bengaluru based Rhea Healthcare Pvt. Ltd. as its recent investment in healthcare space in India.
Deloitte
In 2014 we published a report on End of Life Care in the UK and subsequently have written a number of related blogs on this important subject.
TMT Law Practice
""If I said tennis is totally clean, I would be kidding myself [..] I would say there are certainly some short cuts being taken. Not that many, but it would be crazy to think differently." - Nick Bollettieri
PSA Legal Counsellors
This move not only makes clinical trials for academic research on drugs more cost effective and efficient, but also promotes innovation in terms of treatment of critical maladies like AIDS, cancer, etc.
Khaitan & Co
The Competition Appellate Tribunal (COMPAT) on 10 May 2016 has passed a landmark decision setting aside the Competition Commission of India's (CCI) decision in P K Krishnan v Paul Madavana and Ors.
Nishith Desai Associates
A Roundtable on Cloud Computing – Privacy, Security & Legal Compliance Considerations in the Digital Transformation of Healthcare in India, Part 3 (Apr 26, 2016).
Most Popular Recent Articles
Singh & Associates
Global drug manufacturers represented by the Organisation of Pharmaceutical Producers of India (OPPI) have sought ‘legislative review' of the section 3(d) of the Indian Patents Act and a redefining of the ‘efficacy criteria'.
Singh & Associates
The calculation methodology of the fixation of price for drugs is a complicated one and recently we have come across yet another case of using incorrect methodology for price fixation...
S.S. Rana & Co. Advocates
In 2015, India's apex food regulator, theFSSAI, had ordered recall of energy drinks, Tzinga, Cloud 9, Monster Energy from the market declaring ingredients in these energy beverages were not safe.
Singh & Associates
The India Patent Office in its order issued on 18th November 2016, has denied a patent for the prostate cancer drug sold under the brand name Xtandi (generic name Enzalutamide).
Khaitan & Co
At present, the Drugs and Cosmetics Rules, 1945 (Drugs Rules) regulate 15 categories of medical devices as drugs.
S.S. Rana & Co. Advocates
In a recent case decided by the Delhi High Court, Justice R.K.Gauba granted temporary injunction in favor of Intas Pharmaceuticals Ltd restraining the use of its trademark by the Macleods Pharmaceuticals Ltd.
Tuli & Co
Health insurance business in India has, traditionally, been regulated by the framework governing general insurance business as issued by the Insurance Regulatory and Development Authority of India (IRDAI)...
Khaitan & Co
The Hon'ble Supreme Court of India has, in the case of State of Uttar Pradesh v Dr Dinesh Singh Chauhan, struck down the practice of grant of reservation for in-service candidates in post graduate medical degree courses.
Singh & Associates
According to the eighth annual survey conducted by the Association of Biotechnology-Led Enterprises and Bio Spectrum, the Indian biotech industry grew threefold in just five years to report revenues of US$ 3 billion in 2009-10, a rise of 17 per cent over the previous year.
ARA LAW
While the economy is witnessing a fast transition from "offline" to "online" markets and there is a sturdy buzz of "demonetization" and "one click" access to everything, . . .
Article Search Using Filters
Related Topics
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with